Andere Sprachen Moderna, Inc.

Aktien

A2N9D9

US60770K1079

MRNA

Pharmazeutika

Markt geschlossen - Nasdaq Andere Börsenplätze 22:00:00 16.06.2026			Nachbörslich 02:00:00
55.40 ^USD	+6.27%		54.82	-1.06%

16.06.	US-Aktienmärkte schließen uneinheitlich: Dow markiert Rekordhoch bei sinkenden Ölpreisen und Tech-Ausverkauf	MT
16.06.	MÄRKTE USA/Schwächer - Dow aber im Plus - Brent-Ölpreis unter 80 USD	DJ

Andere Sprachen

16.06.	US Equity Markets End Mixed as Dow Hits Record High Amid Lower Crude Oil Prices, Tech Stock Sell-Off
16.06.	Datos podrían respaldar uso de vacuna contra la gripe de Moderna en adultos mayores: personal de la FDA
16.06.	Moderna flu shot data may support use in older adults, US FDA staff says
16.06.	Ebola Bundibugyo vaccine candidates could enter Phase 1 trials as early as July
16.06.	US FDA staff says data may support effectiveness of Moderna's flu vaccine in older adults
16.06.	Moderna announces executive changes ahead of potential launches
16.06.	Moderna Announces Organizational Changes to Prepare for Multiple Product Launches in 2027 and 2028
15.06.	Elicio shares slide after pancreatic cancer vaccine falls short in mid-stage study
09.06.	Las vacunas contra el cáncer basadas en ARNm avanzan a pesar de los recortes en EEUU
09.06.	What Bundibugyo Ebola vaccines and treatments are under development
09.06.	Cancer vaccines based on mRNA advance, despite US cuts
09.06.	Moderna, University of Oxford Receive UK Approval to Begin Study of Cancer Vaccine
09.06.	Moderna Receives UK Authorization to Evaluate Cancer Vaccine for Lynch Syndrome
09.06.	Moderna and the University of Oxford Receive UK Authorization to Begin Phase 1/2 Study of Investigational mRNA Cancer Vaccine for People with Lynch Syndrome
04.06.	What Bundibugyo Ebola vaccines and treatments are under development
03.06.	HEALTH ROUNDS-Radiation-emitting implant improves outcomes after brain cancer surgery
02.06.	Moderna to Present at Upcoming Conference in June 2026
02.06.	Drugmaker Moderna, other groups get $60 mln to develop Ebola vaccine
01.06.	Jefe de OMS se reúne con presidente del Congo, grupo dice que ébola pudo propagarse por meses sin ser detectado
01.06.	WHO chief wraps up visit to Ebola-hit Congo, briefs president on response
01.06.	Moderna and Merck Present 5-Year Data for Intismeran Autogene in Combination With KEYTRUDA (pembrolizumab) in Patients With High-Risk Stage III/IV Melanoma Following Complete Resection at the 2026 ASCO Annual Meeting
01.06.	Ebola-Moderna va participer au développement d'un vaccin contre la souche Bundibugyo
01.06.	Moderna Expands Collaboration With CEPI to Develop Bundibugyo Ebolavirus Vaccine
01.06.	USA-Les valeurs à suivre à Wall Street (actualisé)
01.06.	Moderna and other groups get $60 million to develop Ebola vaccine